XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:        
Consolidated net (loss) income $ (3,984,109) $ 1,849,501 $ (9,988,942) $ (3,774,563)
Net loss from discontinued operations (336,195) (33,791) (403,120) (272,397)
Net loss from continuing operations (3,647,914) 1,883,292 (9,585,822) (3,502,166)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities from continuing operations:        
Depreciation and amortization     255,601 388,560
Loss on write-off of property and equipment     5,212  
Unrealized gain on change in fair value of warrants classified as a liability (6,410) (5,160,000) (318,840) (9,564,000)
Unrealized loss on change in fair value of warrants classified as a liability-warrant modification       394,000
Transaction costs allocated to warrant liabilities       633,198
Loss on issuance of warrants       1,633,767
Stock-based compensation     80,373 542,045
Change in provision for bad debts     5,423  
Change in operating assets and liabilities:        
Accounts receivable     33,782 (231,325)
Inventories     94,002 (145,847)
Prepaid expenses, other current assets and deposits     417,738 (3,528)
Accounts payable and accrued liabilities     (172,657) (442,797)
Deferred revenue     43,500 (25,150)
Net cash used in operating activities from continuing operations     (9,141,688) (10,323,243)
Cash flows from investing activities:        
Purchase of property and equipment     (313,121) (36,654)
Net cash used in investing activities from continuing operations     (313,121) (36,654)
Cash flows from financing activities:        
Net proceeds from exercise of warrants     2,215,828 394
Net proceeds from issuance of common stock and pre-funded warrants     5,712,700 13,788,923
Net cash provided by financing activities from continuing operations     7,928,528 13,789,317
CASH FLOWS FROM DISCONTINUED OPERATIONS        
Cash used in operating activities     (185,679) (139,089)
Cash provided by investing activities     21,000 0
Net cash used by discontinued operations     (164,679) (139,089)
Net (decrease) increase in cash, cash equivalents and restricted cash     (1,690,960) 3,290,331
Cash, cash equivalents and restricted cash at beginning of period     7,181,095 7,901,800
Cash, cash equivalents and restricted cash at end of period 5,490,135 11,192,131 5,490,135 11,192,131
Less: cash and cash equivalents of discontinued operations (12,458) (534,415) (12,458) (534,415)
Cash, cash equivalents and restricted cash of continuing operations at end of period $ 5,477,677 $ 10,657,716 5,477,677 10,657,716
Non-cash investing and financing activities:        
Transaction costs included in accounts payable       390,721
Deemed dividend warrant modifications     54,326,896 233,087
Warrants issued, cashlessly     $ 610  
Property and equipment acquired and included in accounts payable       $ 275,251